The Global Health Research Network for Healthcare Organizations, BioPharma & CROs.


125 Cambridgepark Drive, Suite 500
Cambridge, MA 02140

Company Overview

TriNetX is bringing together healthcare organizations, biopharma companies and contract research organizations (CROs) for one common purpose: To accelerate the clinical trial design and recruitment process and bring new therapies to market faster.

Utilizing our cloud-based, health research platform, TriNetX Live, members can analyze patient populations with search criteria across multiple longitudinal data points and TriNetX’s advanced analytics modules provide intelligence on which criteria have the most impact as well as the rate at which new patients present. Each data point in the TriNetX network can be traced to healthcare organizations who have the ability to identify individual patients, allowing clinical researchers to develop virtual patient cohorts that can be found in real-world clinical trial settings. Patients can be discovered for industry-sponsored and investigator-initiated studies, as well as for collaboration with peer research institutions. Data in the TriNetX network is fully de-identified to the user and all PHI remains local.

Open Jobs

TriNetX Make an Impact

TriNetX Our Mission

TriNetX Join Our Team

TriNetX Benefits & Perks



February 20, 2018
Cambridge, MA, February 20, 2018 — Boston Children’s Hospital, the top ranked pediatric hospital in the nation according to U.S. News and World Report, has joined the TriNetX global health research network to further its efforts at bringing a more data-driven approach to clinical research. The trend in the healthcare industry is to gain access […]...
February 13, 2018
Unveils Enhanced Real World Data and Analytics for Oncology Clinical Trials Orlando, FL (SCOPE Summit), February 13, 2018 — TriNetX, the global health research network representing nearly 100 million patients, has developed a groundbreaking chemotherapy lines of treatment identification algorithm that understands treatment patterns to deduce the line of chemotherapy treatment a patient is undergoing. This information, up to now near...
January 31, 2018
LONDON, 31 January 2018 — Plymouth Hospitals NHS Trust, the largest hospital in the South West Peninsula region of England, has joined TriNetX’s global health research network to help bring new therapies to its patients faster by gaining access to the earliest and most innovative clinical trials being conducted both home and abroad. TriNetX is […]...
January 29, 2018
Cambridge, MA, January 29, 2018 —TriNetX today announced that Weill Cornell Medicine has joined the TriNetX global health research network. Weill Cornell Medicine is one of the nation’s most comprehensive, integrated academic healthcare delivery systems, and is making its total patient population of over two million available for query through TriNetX’s federated network. TriNetX is a […]...
January 16, 2018
TriNetX technology helps Sanofi streamline clinical trial protocols, improve efficiency and extend Sanofi’s global digital strategy Cambridge, MA, January 16, 2018 – Scientists increasingly rely on the latest computer technology to make their work more efficient and more effective. Nowhere is that more important than in biopharmaceuticals, where the right application of technology can accelerate […]...

Open Jobs